SpringWorks Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Company Overview - SpringWorks Therapeutics is a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer [3] - The company applies a precision medicine approach to develop and deliver life-changing medicines [3] - OGSIVEO® (nirogacestat) is the company's first FDA-approved therapy for adult patients with progressing desmoid tumors requiring systemic treatment [3] - SpringWorks has a diversified targeted therapy pipeline spanning solid tumors and hematological cancers, with programs from preclinical development to advanced clinical trials [3] - The company has entered into multiple collaborations with industry and academia to unlock the full potential of its portfolio [3] Upcoming Event - SpringWorks Therapeutics CEO Saqib Islam will present at the 43rd Annual J P Morgan Healthcare Conference on January 13, 2025 at 11:15 a m PT [1] - The live webcast can be accessed on the company's website, with a replay available for a limited time [2] Additional Information - More information about SpringWorks Therapeutics is available on their website and social media channels [4]